3,4-dihydroxybenzylamine has been researched along with hydroxyurea in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FitzGerald, GB; Wick, MM | 3 |
| FitzGerald, GB; Ratliff, J; Wick, MM | 1 |
4 other study(ies) available for 3,4-dihydroxybenzylamine and hydroxyurea
| Article | Year |
|---|---|
Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Deoxyuracil Nucleotides; Depression, Chemical; DNA Replication; Dopamine; Floxuridine; Humans; Hydroxyurea; Leukemia L1210; Melanoma, Experimental; Methotrexate; Neoplasm Proteins; Thymidylate Synthase | 1987 |
Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine.
Topics: Animals; Cytarabine; Daunorubicin; Deoxyuridine; DNA; Dopamine; Floxuridine; Hydroxyurea; Kinetics; Leukemia L1210; Methotrexate; Thymidylate Synthase | 1987 |
Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes.
Topics: Animals; Antineoplastic Agents; Dopamine; Fluorouracil; Hydroxyurea; Kinetics; Leukemia L1210; Levodopa; Mice; Ribonucleotide Reductases; Thymidylate Synthase | 1986 |
Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine.
Topics: Animals; Antineoplastic Agents; Cell Line; Dithioerythritol; Dopamine; Hydroxyurea; Kinetics; Leukemia L1210; Levodopa; Male; Mice; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases; Structure-Activity Relationship | 1985 |